Goldman Sachs Asks 'Is Curing Patients A Sustainable Business Model?'Turning the search for medical remedies into a numbers game, analyst Salveen Richter called potential "one shot cures" a bad business decision that will hurt a company's bottom line.
Jury Selection In Insider Trading CaseA Connecticut man faces conspiracy and securities fraud charges that carry a potential for more than 100 years in prison in an insider trading trial getting underway in New York today.
Westport Man Indicted On Insider Trading ChargesA former board member of Goldman Sachs and Procter & Gamble surrendered Wednesday to face a six-count securities fraud indictment that makes him the latest defendant in the biggest insider trading case in history.

Listen Live